期刊
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
卷 14, 期 1, 页码 1-16出版社
KOREAN COLL NEUROPSYCHOPHARMACOLOGY
DOI: 10.9758/cpn.2016.14.1.1
关键词
Depression; Remission; Cognition; Occupational outcome
资金
- Lundbeck
- Astra Zeneca
- Pfizer
- Shire
- Otsuka
- Bristol Myers Squibb
- National Institute of Mental Health
- Stanley Medical Research Institute
- Canadian Institutes for Health Research
- Brain and Behavior Research Foundation
- Elli Lilly
- Janssen Ortho
- Sunovion
- Forest
- Takeda
Cognitive deficits in major depressive disorder (MDD) patients have been described in numerous studies. However, few reports have aimed to describe cognitive deficits in the remitted state of MDD and the mediational effect of cognitive deficits on occupational outcome. The aim of the current review is to synthesize the literature on the mediating and moderating effects of specific domains of cognition on occupational impairment among people with remitted MDD. In addition, predictors of cognitive deficits found to be vocationally important will be examined. Upon examination of the extant literature, attention, executive function and verbal memory are areas of consistent impairment in remitted MDD patients. Cognitive domains shown to have considerable impact on vocational functioning include deficits in memory, attention, learning and executive function. Factors that adversely affect cognitive function related to occupational accommodation include higher age, late age at onset, residual depressive symptoms, history of melancholic/psychotic depression, and physical/psychiatric comorbidity, whereas higher levels of education showed a protective effect against cognitive deficit. Cognitive deficits are a principal mediator of occupational impairment in remitted MDD patients. Therapeutic interventions specifically targeting cognitive deficits in MDD are needed, even in the remitted state, to improve functional recovery, especially in patients who have a higher risk of cognitive deficit.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据